Could a Bacteria-Based injection prevent implant complications?

NCT ID NCT07460297

ENROLLING_BY_INVITATION Disease control Sponsor: Jianyi Li Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an inactivated Pseudomonas aeruginosa injection, combined with an iodine wash, can reduce complications like infection and capsular contracture in women undergoing immediate breast reconstruction with implants after cancer surgery. The trial involves 100 participants and measures how quickly drainage tubes can be removed and how well the implant capsule forms. The goal is to improve recovery and patient satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Inactivated Pseudomonas aeruginosa injection (PAP) and povidone-iodine
What this could lead to
If it works, this could reduce infection and capsular contracture after breast reconstruction, improving recovery and satisfaction.
What could go wrong
This is an early-stage trial with only 100 participants, so results may not apply widely. The treatment involves a bacterial injection, which could cause unexpected inflammation or side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DUCTAL CARCINOMA IN SITU are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Liaoning Cancer Hospital and Institute

    Shenyang, Liaoning, 110000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.